Southpoint Capital Advisors LP

Fennec Pharmaceuticals Inc. · 10% Owner

Southpoint Capital Advisors LP is listed in public filings as 10 percent owner. This Southpoint Capital Advisors LP insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Fennec Pharmaceuticals Inc. (FENC). Investors use Southpoint Capital Advisors LP's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Fennec Pharmaceuticals Inc.FENC$7.5M1M sharesSellDec 24, 2025$7.50--